Liver transplant disqualification is rarely a single yes-or-no decision. Transplant teams weigh a mix of medical, surgical, behavioral, and psychosocial factors, and most of these sit on a spectrum rather than acting as hard cutoffs. Only a handful of conditions are treated as absolute barriers at virtually every transplant center, while a much larger set of issues can count against you depending on severity, your overall health picture, and even which hospital you’re evaluated at. Understanding the difference between an absolute contraindication and a relative one is the key to making sense of the process.
Absolute Versus Relative Contraindications
Transplant medicine divides disqualifying factors into two buckets. An absolute contraindication means the transplant will almost certainly fail or that no ethical case can be made for proceeding. A relative contraindication means the factor raises risk but does not automatically rule you out. Most of the barriers people worry about fall into the relative category, where the transplant team has discretion to weigh the factor against the urgency of your liver disease and the likelihood of a good outcome.
The short list of near-universal absolute contraindications includes widespread cancer that has spread beyond the liver, severe and irreversible brain damage, active untreated sepsis, and advanced cardiopulmonary disease that cannot be corrected. Everything else, from age to obesity to substance use history, lands in grayer territory. That gray zone is where most of the real-world disputes about eligibility happen, and it is where center-to-center variation is largest.
Cancer That Has Spread or Is Too Advanced
If cancer has metastasized widely, transplant is off the table because the immunosuppression drugs you would need after surgery would let the remaining cancer grow unchecked. For liver cancer that is confined to the liver, eligibility depends heavily on tumor size and number. The most widely used benchmark is the Milan criteria, which limit transplant candidacy to patients whose tumors fall within specific size thresholds. Patients who meet these criteria have shown five-year survival rates above 70% after transplant, which is why the criteria have become the global standard.
The trade-off is that the Milan criteria are conservative. They deny transplant to some patients whose tumors are only slightly more advanced and who might still do well with a new liver. Several expanded criteria sets have been proposed to capture those patients, but the core Milan framework remains the default at most centers.
1PubMed Central. Selection of patients of hepatocellular carcinoma beyond the Milan criteria for liver transplantationCancers originating outside the liver are handled differently. If you had a prior malignancy that was successfully treated and enough time has passed without recurrence, you may still qualify. But an active extrahepatic cancer, one that is growing somewhere other than the liver, is considered an absolute contraindication at essentially every program.
Heart and Lung Problems
Liver transplant surgery is long and physically brutal, so your heart and lungs have to be strong enough to survive it. This is not a trivial concern. Estimates suggest that roughly a quarter of all liver transplant candidates have at least one critically narrowed coronary artery, and about half of those patients die during or shortly after surgery from cardiac complications.2PubMed Central. Cardiac evaluation of liver transplant candidates That is why every candidate undergoes detailed cardiac testing. Severe, uncorrectable coronary artery disease or advanced heart failure that cannot be managed will disqualify you.
On the lung side, a condition called portopulmonary hypertension, where high blood pressure develops in the arteries between the heart and lungs as a result of liver disease, is common enough to warrant specific screening. Current guidelines from the American Association for the Study of Liver Diseases treat a mean pulmonary artery pressure of 45 mmHg or higher, combined with elevated pulmonary vascular resistance despite treatment, as a contraindication to transplant.3PubMed Central. AASLD AST Practice Guideline on Adult Liver Transplantation: Candidate Evaluation – Section: Pulmonary Evaluation Below that threshold, the condition is manageable, and transplant can still proceed if pressures respond to medication.
Alcohol Use and the Six-Month Rule
Alcohol-associated liver disease is now one of the most common reasons people need a liver transplant, and substance use policies remain among the most contested aspects of the eligibility process. Traditionally, most transplant programs required a minimum of six months of documented sobriety before they would list a patient. The logic was partly medical, to see whether the liver might recover on its own once drinking stopped, and partly a way to demonstrate commitment to long-term sobriety.
That six-month rule has come under serious scrutiny. For patients with severe acute alcoholic hepatitis who are not responding to medical treatment, the majority will die before six months have passed, making the rule essentially a death sentence for that group.4PubMed Central. Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients Research has increasingly challenged the assumption that early transplant leads to worse outcomes. A study comparing patients who received “early” liver transplants for alcohol-associated liver disease (before completing six months of abstinence) with those who met the standard waiting period found that one-year and three-year survival were statistically indistinguishable between the two groups.5JAMA Surgery. Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease
As a result, many programs have moved away from a rigid six-month cutoff and now evaluate alcohol use on a case-by-case basis. They look at factors like the severity of liver failure, engagement with addiction treatment, psychosocial stability, and the patient’s overall prognosis without a transplant. That said, active, untreated alcohol use disorder with no engagement in treatment remains a strong barrier at virtually every center.
Marijuana, Tobacco, and Other Substances
Marijuana policies have shifted dramatically. For years, a positive cannabis test could get you turned down or removed from the waitlist. The evidence, however, does not support that approach. One study of nearly 1,500 transplant candidates found that marijuana users had survival rates similar to non-users, and that marijuana use was not an independent predictor of worse outcomes.6PubMed. Marijuana use in potential liver transplant candidates A separate analysis using competing risk models confirmed that marijuana use was not associated with either the probability of receiving a transplant or with waitlist mortality.7PubMed Central. History of marijuana use does not affect outcomes on the liver transplant waitlist In a survey of Canadian transplant programs, 71% reported that cannabis use is rarely or never treated as a contraindication.8PubMed Central. Assessment of Canadian policies regarding liver transplant candidacy of people who use alcohol, tobacco, cannabis, and opiates
Illicit drugs other than cannabis are a different story. Recent use of substances like cocaine or methamphetamine was associated with nearly double the risk of death or delisting compared to patients who had never used those drugs.7PubMed Central. History of marijuana use does not affect outcomes on the liver transplant waitlist Active use of hard drugs is treated as a strong relative or absolute contraindication at most programs, primarily because of the interaction between these substances and post-transplant immunosuppressive medications, as well as concerns about long-term adherence to the medical regimen.
Tobacco occupies an intermediate zone. Around 29% of Canadian programs require smoking cessation before considering a patient for transplant, reflecting a growing recognition that smoking increases surgical risk and worsens long-term cardiovascular outcomes after transplant.8PubMed Central. Assessment of Canadian policies regarding liver transplant candidacy of people who use alcohol, tobacco, cannabis, and opiates But tobacco use alone rarely results in outright denial; instead, patients are typically required to enter a cessation program and demonstrate progress.
The Psychosocial Evaluation
Liver transplant eligibility is not purely a medical decision. Every candidate goes through a psychosocial assessment that looks at mental health, social support, substance use history, and readiness to manage the lifelong demands of post-transplant care. Many centers use a standardized tool called the Stanford Integrated Psychosocial Assessment for Transplantation, or SIPAT, which scores candidates across four domains: treatment readiness, social support, psychological comorbidities, and substance use.9PubMed. The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT): a new tool for the psychosocial evaluation of pre-transplant candidates
Higher scores on the SIPAT, indicating more psychosocial risk, have been linked to poorer outcomes. In one analysis, scores in the readiness, psychosocial comorbidities, and substance use domains were each associated with a return to alcohol use after transplant.10PubMed Central. Psychosocial assessment in liver transplantation (LT): an analysis of short-term outcomes The social support score, interestingly, was not a significant predictor in that study. Still, lack of social support matters in a broader sense: a national survey of transplant providers estimated that roughly 10% of patients evaluated in the prior year were excluded because of inadequate support, such as having no one to help with medications and follow-up appointments after surgery.11PubMed Central. Excluding patients from transplant due to social support: Results from a national survey of transplant providers
This part of the evaluation attracts the most ethical debate. Denying a lifesaving surgery because someone lacks a stable caregiver or has poorly controlled depression can feel like punishing people for their circumstances rather than their medical prognosis. Programs are increasingly asked to distinguish between fixable barriers (helping a patient find support resources, connecting them with psychiatric treatment) and truly intractable ones.
Non-Adherence to Medical Treatment
After transplant, you will take immunosuppressive medications for the rest of your life. Missing doses leads to rejection of the new liver, and the consequences can be fatal. That is why a documented pattern of not following medical advice before transplant raises a major red flag. Habitual non-adherence is widely considered a contraindication, particularly for patients seeking a second transplant after losing the first graft.12PubMed Central. Medical adherence and liver transplantation: a brief review
Research bears this out: patients with chart evidence of non-adherence before transplant were significantly more likely to show erratic drug levels and non-adherence behavior after transplant as well.13PubMed. Non-adherence and graft failure in adult liver transplant recipients Transplant teams look for patterns like repeatedly missing clinic appointments, not taking prescribed medications, or failing to follow through on pre-transplant requirements like weight loss or addiction counseling. A single lapse is rarely disqualifying on its own, but a persistent pattern can be.
Surgical and Anatomical Challenges
Even when you are otherwise eligible, certain anatomical situations can make the surgery itself impossible or extremely dangerous. One of the most significant is extensive portal vein thrombosis, where blood clots block the major veins that feed the liver. When thrombosis is limited to the portal vein itself, surgeons can often work around it. But when clotting extends throughout the portal vein, the splenic vein, and the superior mesenteric vein, no standard blood vessel remains to connect the new liver to the blood supply.14Journal of Hepatology. Frontiers in Liver Transplantation Portal vein thrombosis, cirrhosis, and liver transplantation – Section: Patients with diffuse splanchnic vein thrombosis Complete portomesenteric thrombosis is sometimes treated as grounds for denying transplant, with a multivisceral transplant (replacing several abdominal organs at once) being the only alternative.15International Journal of Surgery. Current management of portal vein thrombosis in liver transplantation
Previous extensive abdominal surgery can also complicate things, though it is rarely disqualifying by itself. The concern is dense scar tissue (adhesions) that increases the difficulty and length of the operation. Surgeons account for this during planning rather than using it as a reason to deny the transplant.
Severe Brain Injury in Acute Liver Failure
Acute liver failure can cause catastrophic brain swelling. In patients being evaluated for emergency transplant, a CT scan showing severe cerebral edema before surgery is associated with either death shortly after transplant or permanent neurological deficits in survivors.16PubMed. Long-term outcomes of emergency liver transplantation for acute liver failure For this reason, severe preoperative brain swelling is treated as a relative contraindication. The thinking is straightforward: transplanting a liver into a patient who has already suffered irreversible brain damage would succeed surgically but leave the patient with a devastating quality of life, or would fail entirely because the brain injury is already fatal.
Obesity and Body Weight
Severe obesity does not automatically disqualify you, but it does raise surgical risk and can push a case into the “too risky” category. Patients with class 2 or class 3 obesity (generally a BMI of 35 or higher) had roughly double the odds of venous thrombosis and about two and a half times the odds of wound complications compared to non-obese recipients. Hospital stays were also significantly longer.17PubMed Central. Association of body mass index with post-liver transplant outcomes Some programs set a BMI ceiling (often around 40) above which they will not list patients, while others evaluate each case individually. If weight loss before transplant is realistic and achievable, teams typically work with the patient to reach a safer weight rather than issuing an outright denial.
Age and Physical Frailty
There is no absolute age cutoff for liver transplant, but the reality is that outcomes are worse at the extremes. Most programs become cautious with candidates over 70, and very few will transplant someone over 75 unless the patient is in unusually good condition. Age itself, though, matters less than the frailty it sometimes brings. Frailty, the combination of muscle wasting, poor endurance, slow walking speed, and general physical deconditioning, has emerged as one of the strongest predictors of poor post-transplant outcomes.
Expert consensus from the American Society of Transplantation holds that every transplant candidate should be assessed for frailty using a standardized tool, both at the start and repeatedly over time. The same consensus is clear, however, that frailty should not be used as the sole reason to delist someone. It should be one factor among many, and teams should be investing in nutrition and physical rehabilitation to improve a patient’s frailty status before making a final eligibility decision.18PubMed Central. Frailty in liver transplantation: An expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice
Financial and Insurance Barriers
This is the disqualification factor people are least comfortable talking about. A liver transplant costs several hundred thousand dollars, and the post-transplant medications alone run thousands of dollars per year for life. Transplant centers are permitted to consider a patient’s ability to pay when deciding whether to list them. As one analysis in JAMA put it, the listing system allows centers to factor in financial resources when making their initial waitlisting decision, which effectively means withholding lifesaving therapy from people who are deemed to lack sufficient resources.19JAMA. Medical Need, Financial Resources, and Transplant Accessibility
In practice, this means patients without insurance, with inadequate insurance, or with no way to cover post-transplant drug costs may be turned down or told to find additional funding before being listed. Programs vary widely in how rigidly they enforce financial requirements. Some have dedicated social workers and fundraising support to help patients navigate this barrier; others are less flexible. Medicaid coverage, charity care programs, and pharmaceutical assistance plans can fill gaps, but the system is undeniably tilted against patients with fewer financial resources.
What Happens When You Are Delisted
Being removed from the transplant waitlist is not always permanent, and the reasons vary. In one observational study, the most common reason for delisting was that the patient had improved enough that they no longer needed a transplant (54% of cases). About 22% were delisted because they had become too sick for surgery, 12% for adherence issues, and 11% because the treatment goal changed (such as a shift to palliative care). The five-year survival rates after delisting were starkly different: 84% for those who had improved, but only 9% for those who were removed for being too sick.20PubMed Central. Frequent Follow-Up of Delisted Liver Transplant Candidates Is Necessary: An Observational Study about Characteristics and Outcomes of Delisted Liver Transplant Candidates
If you are delisted for a correctable reason, such as substance use relapse, weight, or adherence problems, you can often be relisted once the issue is resolved. Frequent follow-up after delisting is critical, because liver disease can worsen again and the window for relisting may be narrow.
Center-to-Center Variation and Second Opinions
One of the most frustrating aspects of the transplant evaluation process is that eligibility standards are not uniform across the country. A patient declined at one center may be accepted at another. This is partly because relative contraindications involve judgment calls that different teams weigh differently, and partly because centers have different levels of surgical expertise and comfort with high-risk cases. When a national survey asked transplant centers whether they favored standardizing the evaluation process, only 38% were in favor, while 39% opposed it and 23% were unsure.21PubMed. National survey of second opinions for hospitalized patients in need of liver transplantation
That split tells you something important: the transplant community itself has not reached consensus on how uniform the process should be. The practical takeaway for patients is that a denial from one center is not necessarily the final word. Seeking a second opinion at a different transplant program is both common and reasonable, especially if the stated reason for denial involves a relative contraindication or a psychosocial concern rather than a clear-cut absolute barrier. Allocation of donated livers is meant to follow ethical and, where possible, evidence-based criteria to balance competing values like equity, medical urgency, and predicted benefit.22Gut. Selection of patients for liver transplantation and allocation of donated livers in the UK In practice, how those values are weighed still depends heavily on the institution doing the weighing.